SEMA3A and glioblastoma: Interestingly, Bagci and coworkers [30] provided evidence that GBM cells engineered to overexpress Sema3A, displayed reduced scattering instead of the cell spreading promoted by the endogenous molecule; thus, these authors suggested a dose-dependent “biphasic model” for GBM cell control by this signal.